Skip to main content

Advertisement

SpringerLink
Log in

Pre-exposure Prophylaxis for HIV Infection: Preventing Disease or Promoting Sexual Health?

  • Commentary
  • Published:
Journal of Community Health Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. World Health Organization. (1946). Constitution of the World Health Organization. Retrieved Oct 25, 2018, from https://www.who.int/about/mission/en/.

  2. Edwards, W. M., & Coleman, E. (2004). Defining sexual health: A descriptive overview. Archives of Sexual Behavior, 33(3), 189–195.

    Article  PubMed  Google Scholar 

  3. World Health Organization. (2010). Developing sexual health programs: A framework for action. Retrieved Oct 29, 2018, from https://www.who.int/reproductivehealth/publications/sexual_health/rhr_hrp_10...en/.

  4. Ford, J. V., Ivankovich, M. B., Douglas, J. M., et al. (2017). The Need to promote sexual health in America: A new vision for public health action. Sexually Transmitted Diseases, 44(10), 579–585.

    Article  PubMed  Google Scholar 

  5. Grant, R. M., Lama, J. R., Anderson, P. L., et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.

    Article  CAS  PubMed  Google Scholar 

  6. Smith, D. K., Grant, R. M., Weidle, P. J., Lansky, A., Mermin, J., & Fenton, K. A. (2011). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Report, 60(3), 65–68.

    Google Scholar 

  7. Smith, D. K., Thigpen, M. C., Nesheim, S. R., et al. (2012). Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. Morbidity and Mortality Weekly Report, 61(31), 586–589.

    Google Scholar 

  8. Smith, D. K., Martin, M., Lansky, A., Mermin, J., & Choopanya, K. (2013). Update to interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. Morbidity and Mortality Weekly Report, 62(23), 463–465.

    PubMed Central  Google Scholar 

  9. Food and Drug Administration. (2012). FDA approves first drug for reducing the risk of sexually acquired HIV infection. Retrieved Oct 31, 2018, from https://aidsinfo.nih.gov/news/1254/fda-approves-first-drug-for-reducing-the-risk-of-sexually-acquired-hiv-infection.

  10. Centers for Disease Control and Prevention: US Public Health Service. (2014). Preexposure Prophylaxis for the Prevention of HIV Infection in the United States: A Clinical Practice Guideline. Published May 14, 2014. Note: 2014 PrEP Guidelines are no longer maintained by CDC.

  11. Ryan, B. (2018). FDA Approves Truvada as PrEP for Adolescents at Risk for HIV. POZ. Retrieved Nov 1, 2018, from https://www.poz.com/articel/fda-approves-truvada-prep-adolescents-risk-hiv.

  12. Office of National AIDS Policy. (2015). National HIV/AIDS Strategy for the United States: Updated to 2020. Retrieved Nov 3, 2018, from https://obamawhitehouse.archives.gov/sites/default/files/docs/national_hiv_aids_strategy_update_2020.pdf.

  13. Jenness, S. M., Goodreau, S. M., Rosenberg, E., Beylerian, E. N., Hoover, K. W., Smith, D. K., & Sullivan, P. (2016). Impact of the Centers for Disease Control’s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. Journal of Infectious Diseases, 214(12), 1800–1807.

    Article  PubMed  Google Scholar 

  14. Sullivan, P. S., Giler, R. M., Mouhanna, F., et al. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Annals of Epidemiology, 12(12), 833-840.

  15. Huang, Y. A., Zhu, W., Smith, D. K., Harris, N., & Hoover, K. W. (2018). HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morbidity and Mortality Weekly Report, 67(41), 1147–1150.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Harawa, N., McBride, S., Leibowitz, A., Pulsipher, C., & Holloway, I. (2018). Examining PrEP Uptake among Medi-Cal Beneficiaries in California: Differences by Age, Gender, Race/Ethnicity and Geographic Region. California HIV/AIDS Policy Research Centers. Retrieved Nov 5, 2018, from http://www.chprc.org/examining-prep-uptake-among-medi-cal-beneficiaries-in-california/.

  17. Green, L. W., Ottoson, J. M., Garcia, C., & Hiatt, R. A. (2009). Diffusion theory and knowledge dissemination, utilization and integration in public health. Annual Review of Public Health, 30, 151–174.

    Article  PubMed  Google Scholar 

  18. Smith, D. K., Mendoza, M. C., Stryker, J. E., & Rose, C. E. (2016). PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS ONE, 11 (6), e0156592.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Misra, K., & Udeaugu, C. C. (2017). Disparities in awareness of HIV postexposure and preexposure prophylaxis among notified partners of HIV-positive individuals, New York City 2015–2017. Journal of Acquired Immune Deficiency Syndromes, 76(2), 132–140.

    Article  PubMed  Google Scholar 

  20. Eaton, L. A., Kalichman, S. C., Price, D., Finneran, S., Allen, A., & Maksut, J. (2017). Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS and Behavior, 21(5), 1236–1246.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Calabrese, S. K., Dovidio, J. F., Tekeste, M., et al. (2018). HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood. Journal of Acquired Immune Deficiency Syndromes, 79(1), 46–53.

    Article  PubMed  Google Scholar 

  22. Eaton, L. A., Driffin, D. D., Smith, H., Conway-Washington, C., White, D., & Cherry, C. (2014). Psycho-social factors related to willingness to use pre-exposure prophylaxis for HIV prevention among black men who have sex with men attending a community event. Sexual Health, 11(3), 244–251.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lelutiu-Weinberger, C., & Golub, S. A. (2016). Enhancing PrEP access for black and latino men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 73(5), 547–555.

    Article  PubMed  Google Scholar 

  24. Cahill, S., Taylor, S. W., Elesser, S. A., Mena, L., Hickson, D., & Mayer, K. H. (2017). Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care, 29(11), 1351–1358.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Smith, D. K., Van Handel, M., & Grey, J. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology, 28(12), 850-857.

    Article  Google Scholar 

  26. Calabrese, S. K., Earnshaw, V. A., Krakower, D. S., et al. (2018). A closer look at racism and heterosexism in medical students’ clinical decision-making related to HIV pre-exposure prophylaxis (PrEP): Implications for PrEP education. AIDS and Behavior, 22(4), 1122–1138.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Pathela, P., Jamison, K., Braunstein, S. L., Schillinger, J. A., Varma, J. K., & Blank, S. (2017). Incidence and predictors of HIV infection among men who have sex with men attending public sexually transmitted disease clinics, New York City, 2007–2012. AIDS and Behavior, 21(5), 1444–1451.

    Article  PubMed  Google Scholar 

  28. Marx, G. E., Bhatia, R., & Rietmeijer, C. A. (2016). An opportunity too good to miss: Implementing human immunodeficiency virus preexposure prophylaxis in sexually transmitted diseases clinics. Sexually Transmitted Diseases, 43(4), 266–267.

    Article  PubMed  Google Scholar 

  29. Hoover, K. W., Ham, D. C., Peters, P. J., Smith, D. K., & Bernstein, K. T. (2016). Human immunodeficiency virus prevention with preexposure prophylaxis in sexually transmitted disease clinics. Sexually Transmitted Diseases, 43(5), 277–282.

    Article  PubMed  Google Scholar 

  30. Leichliter, J. S., Heyer, K., Peterman, T. A., et al. (2017). US public STD clinical services in an era of declining public health funding, 2013–2014. Sexually Transmitted Diseases, 44(8), 505–509.

    Article  PubMed  PubMed Central  Google Scholar 

  31. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. (2018). New CDC analysis shows steep and sustained increases in STDs in recent years. Retrieved Nov 28, 2018, from http://www.cdc.gov/nchstp/newsroom/2018/press-release-2018-std-prevention-conference.html.

  32. U. S. Office of Disease Prevention and Health Promotion. Healthy People 2020: Public Health Infrastructure. Retrieved Nov 29, 2018, from https://www.healthypeople.gov/2020/topics-objectives/topic/public-health-infrastructure.

  33. Liu, A. Y., Cohen, S. E., Vittinghoff, E., et al. (2016). HIV pre-exposure prophylaxis integrated with municipal and community based sexual health services. JAMA Internal Medicine, 176(1), 75–84.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Parisi, D., Warren, B., Leung, S. Y., Akkaya-Hocagil, T., Qin, Q., Hahn, I., & Stevens, L. (2018). A multicomponent approach to evaluating a pre-exposure prophylaxis (PrEP) implementation program in five agencies in New York. Journal of the Association of Nurses in AIDS Care, 29(1), 10–19.

    Article  CAS  PubMed  Google Scholar 

  35. New York State Department of Health. PrEP Assistance Program (PrEP-AP). Retrieved Dec 4, 2018, from https://www.health.ny.gov/diseases/aids/general/prep/prep-ap_provider.htm.

  36. Patel, R. R., Mena, L., Nunn, A., et al. (2017). Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention. PLoS ONE, 12(5), e0178737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Morgan, E., Ryan, D. T., Newcomb, M. E., & Mustanski, B. (2018). High rate of discontinuation may diminish prep coverage among young men who have sex with men. AIDS and Behavior, 22(11), 3645–3648.

    Article  PubMed  Google Scholar 

  38. McKenney, J., Chen, A., Hoover, K. W., et al. (2017). Optimal costs of pre-exposure prophylaxis for men who have sex with men. PLoS ONE, 12(6), e0178170.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. United Nations General Assembly. (2016). Political declaration on HIV and AIDS: On the fast track to accelerating the fight against HIV and to ending the AIDS Epidemic by 2030. Retrieved Dec 6, 2018, from http://www.unaids.org/sites/default/files/media-asset/2016-political-declaration-HIV-AIDS_en.pdf.

Download references

Author information

Authors and Affiliations

  1. Department of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA

    Ronald O. Valdiserri

  2. School of Public Health, University at Albany, Rensselaer, NY, USA

    David R. Holtgrave

Authors
  1. Ronald O. Valdiserri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David R. Holtgrave
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronald O. Valdiserri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valdiserri, R.O., Holtgrave, D.R. Pre-exposure Prophylaxis for HIV Infection: Preventing Disease or Promoting Sexual Health?. J Community Health 44, 423–427 (2019). https://doi.org/10.1007/s10900-018-00616-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-018-00616-3

Search

Navigation